Diagnostics News and Research

RSS

IRIS International announces renewal of supply agreement with MedAssets Supply Chain Systems

IRIS International, Inc., a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that it has renewed a supply agreement for its full product line of automated and semi-automated urinalysis systems, related products, consumables and services agreements, with MedAssets Supply Chain Systems, one of the largest Group Purchasing Organizations (GPOs) serving healthcare providers nationwide. The new three-year contract is effective April 1, 2010.

26 Apr 2010

SQI Diagnostics signs development agreement with Silliker

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that it has entered into a development agreement with Silliker, Inc., a leading internationally accredited company dedicated to improving nutrition, food safety and quality, for the commercialization of a botulism toxin panel that will run on SQI's SQiDman analytical system.

26 Apr 2010

Beijing Customs seize Biosite's Triage products

Biosite's Triage products imported by Inverness Medical Beijing Co., Ltd. in April 2010 have been seized by Beijing Customs for not complying with the applicable importation regulations. As a result, the Chinese market is facing a severe shortage.

26 Apr 2010

Serum cortisol levels linked with increased mortality in patients with ACS: Research

Growing evidence suggests that serum cortisol levels are associated with increased cardiovascular mortality in patients with chronic heart failure, research presented at this week's European Congress of Endocrinology shows.

26 Apr 2010

Rapid diagnostic tests for malaria

A new evaluation of malaria rapid diagnostic tests will help health workers quickly identify which patients have the disease and need immediate treatment, putting into action recent World Health Organization recommendations to confirm diagnosis of malaria before treatment.

24 Apr 2010

Golub Capital provides $12.0M of senior subordinated debt to support recapitalization of IDT

Golub Capital today announced that it has provided $12.0 million of senior subordinated debt to support the recapitalization and ongoing growth of Integrated DNA Technologies, Inc. This transaction marks the first investment made by GC 2009 Mezzanine Partners, L.P., which is Golub Capital's sixth fund dedicated to middle market mezzanine debt financings.

From Integrated DNA Technologies 24 Apr 2010

New blood test to determine patients at low risk for rejection of transplanted hearts

After his heart transplant in 2005, Ramon Llenado underwent a biopsy every week, then every month, then every three months. Most heart transplant patients face a lifetime of these invasive tests, which involve snipping out tiny pieces of heart to check for possible organ rejection.

23 Apr 2010

Better diagnostics in prostate cancer needed

A flurry of confusing research about the benefits of PSA testing has left many men and their physicians reticent to use a test that may be life-saving, says a panel of prostate cancer experts. The experts who gathered on Capitol Hill in Washington on Tuesday agreed that PSA testing, while not cancer-specific, is one of the best available tools for early detection of a cancer that kills 27,000 American men each year.

23 Apr 2010

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Genentech, Inc., a wholly owned member of the Roche Group, announced today that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Herceptin® (trastuzumab) plus chemotherapy in people with advanced, HER2-positive adenocarcinoma of the stomach, including gastroesophageal junction cancer.

23 Apr 2010

TUM scientists collaborate with Fujitsu Laboratories of Japan to commercialize biosensor chip

In the battle against cancer and other diseases, precise analysis of specific proteins can point the way toward targeted treatments. Scientists at theTechnische Universitaet Muenchen, together with Fujitsu Laboratories of Japan, have developed a novel biosensor chip that not only recognizes proteins that are characteristic for specific diseases, but also can show if these proteins are changed through the influence of disease or drugs.

23 Apr 2010

BUSM professor receives Individual Biomedical Research Award

Richard Goldstein, PhD, a professor of pediatrics, division of pediatric infectious diseases, at Boston University School of Medicine, has been awarded an Individual Biomedical Research Award by The Hartwell Foundation and will receive $300,000 over three years as a Hartwell Investigator for his project titled, "A Vaccine Against Streptococcus Pneumoniae Based on Bacterial Surface Proteins Phylogenically Certified as Highly Conserved."

23 Apr 2010

Pharmaceutical industry faces rapidly changing future: Pharma CI Conference

The pharmaceutical industry finds itself facing a rapidly changing future in light of the health care bill and the evolving pharmaceutical marketplace. There's never been a time when demand has been so intense for the most accurate and up-to-date information about the pharmaceutical industry, especially pharmaceutical competitive intelligence.

22 Apr 2010

Enigma ML instrument system to be showcased at InnovHealth 2010 summit

Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today that it will be a product provider at the InnovHealth - Middle East Healthcare Innovations Summit in Abu Dhabi on 25 and 26 April 2010 and will be presenting the Enigma ("Mini Laboratory") instrument system.

22 Apr 2010

Medical technology innovation strives for personal focus, cost-efficiency

Medtronic CEO Bill Hawkins says the products made by his company, like pacemakers, insulin pumps and neurostimulators are the "ultimate personal technologies," according to CNNMoney. He said a shift in his industry is moving towards health information technology that people will depend on and use with their cell phones and laptops.

22 Apr 2010

Rheonix announces completion of $12.6 million Series A financing

Rheonix, Inc. today announced the completion of a $12.6 million Series A financing to continue development of the Rheonix CARD™ (Chemistry And Reagent Device) system. This powerful, analytic platform for the life-science industry vertically integrates all the functions of traditional molecular diagnostic instrumentation into a single system to achieve unprecedented raw sample preparation, molecular amplification and multiplex analysis.

21 Apr 2010

Abbott's first-quarter worldwide pharmaceutical sales increases by 12.9%

Abbott today announced financial results for the first quarter ended March 31, 2010.

21 Apr 2010

Biomagnetics Diagnostics receives commitment for clinical validation testing in India for malaria, TB diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced it has received important commitments from two leading research laboratories in India for clinical validation testing for malaria and tuberculosis (TB) detection and diagnosis.

21 Apr 2010

Covidien's second-quarter medical devices sales up 11%

Covidien plc today reported results for the second quarter of fiscal 2010 (January - March 2010).

21 Apr 2010

Tea for Teal event raises $15,000 for TGen ovarian cancer research

The Anne Rita Monahan Foundation recently presented $15,000 for ovarian cancer research to the Translational Genomics Research Institute (TGen).

21 Apr 2010

Montgomery Breast Center of Montgomery installs GammaLoc system for biopsy procedures

The Montgomery Breast Center of Montgomery, Ala., is the first center in the country to install and use the GammaLoc lesion-localization system. This system is the only FDA-cleared device that enables gamma-guided, minimally invasive needle biopsy of suspicious lesions identified with Breast-Specific Gamma Imaging.

21 Apr 2010

Diagnostics News and Research

IRIS International announces renewal of supply agreement with MedAssets Supply Chain Systems

SQI Diagnostics signs development agreement with Silliker

Beijing Customs seize Biosite's Triage products

Serum cortisol levels linked with increased mortality in patients with ACS: Research

Rapid diagnostic tests for malaria

Golub Capital provides $12.0M of senior subordinated debt to support recapitalization of IDT

New blood test to determine patients at low risk for rejection of transplanted hearts

Better diagnostics in prostate cancer needed

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

TUM scientists collaborate with Fujitsu Laboratories of Japan to commercialize biosensor chip

BUSM professor receives Individual Biomedical Research Award

Pharmaceutical industry faces rapidly changing future: Pharma CI Conference

Enigma ML instrument system to be showcased at InnovHealth 2010 summit

Medical technology innovation strives for personal focus, cost-efficiency

Rheonix announces completion of $12.6 million Series A financing

Abbott's first-quarter worldwide pharmaceutical sales increases by 12.9%

Biomagnetics Diagnostics receives commitment for clinical validation testing in India for malaria, TB diagnosis

Covidien's second-quarter medical devices sales up 11%

Tea for Teal event raises $15,000 for TGen ovarian cancer research

Montgomery Breast Center of Montgomery installs GammaLoc system for biopsy procedures

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News